Uv curable coating compositions for organic ophthalmic lenses
US-2018113239-A1 · Apr 26, 2018 · US
US12486349B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12486349-B2 |
| Application number | US-202017756865-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 3, 2020 |
| Priority date | Dec 5, 2019 |
| Publication date | Dec 2, 2025 |
| Grant date | Dec 2, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a curable composition including the following components: (i) a first alkoxysilane which is unhydrolyzed; (ii) a second alkoxysilane which is 5 to 45 percent hydrolyzed; and (iii) an ethylenically unsaturated monomer. The invention also provides coatings formed from the curable composition and articles coated with the curable composition.
Opening claim text (preview).
The invention claimed is: 1 . A curable composition comprising the following components: (i) a first alkoxysilane which is unhydrolyzed, present in the curable composition in an amount ranging from 10 to 80 weight percent; (ii) a second alkoxysilane which is 5 to 45 percent hydrolyzed, present in the curable composition in an amount ranging from 5 to 90 weight percent; and an ethylenically unsaturated monomer, present in the curable composition in an amount ranging from 1 to 50 weight percent; wherein weight percentage is based on the total weight of components (i), (ii), and (iii). 2 . The curable composition of claim 1 , wherein component (i) and component (ii) are prepared and added separately. 3 . The curable composition of claim 1 , wherein component (ii) comprises at least 30 percent monomeric alkoxysilane. 4 . The curable composition of claim 1 , wherein the first alkoxysilane and the second alkoxysilane are the same or different. 5 . The curable composition of claim 1 , wherein the first alkoxysilane and the second alkoxysilane each independently has the following structure (I): R x Si(OR′) 4-x (I) wherein: x is 0, 1, 2, or 3; each R is an organic radical independently selected from C 1 to C 6 alkyl, vinyl, alkoxyalkyl, aryl, aryloxyalkyl, γ-glycidoxy alkyl, or γ-(meth)acryloxy alkyl; and each R′ is independently a C 1 to C 4 alkyl group. 6 . The curable composition of claim 1 , further comprising a free-radical initiator selected from the group consisting of thermal initiators, photoinitiators, and mixtures thereof. 7 . The curable composition of claim 6 , wherein the free-radical initiator is a photoinitiator. 8 . The curable composition of claim 1 , wherein each of the first alkoxysilane of component (i) and the second alkoxysilane of component (ii) is independently selected from the group consisting of methyl triethoxysilane, γ-glycidoxypropyl trimethoxysilane, tetramethoxysilane, tetraethoxysilane, acryloxysilane, and mixtures thereof. 9 . The curable composition of claim 5 , wherein R is γ-glycidoxy alkyl and the curable composition further comprises a curing agent comprising a cationic initiator. 10 . The curable composition of claim 9 , wherein the curing agent comprises aryl onium salts of Group VA elements, salts of Group VIA elements, salts of Group VIIA elements, or mixtures thereof. 11 . The curable composition of claim 1 , wherein the ethylenically unsaturated monomer of component (iii) is selected from the group consisting of hexanediol diacrylate, butanediol diacrylate, cycylohexane dimethanol divinylether, and mixtures thereof. 12 . The curable composition of claim 1 , wherein the second alkoxysilane of component (ii) is 10 to 40 percent hydrolyzed. 13 . The curable composition of claim 1 , further comprising a polyglycidyl ether.
containing silicon bound to oxygen-containing groups (C09D183/12 takes precedence) · CPC title
{Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond} in combination with a macromolecular compound other than an unsaturated polymer of groups C09D159/00 - C09D187/00 · CPC title
of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate · CPC title
on to saturated polysiloxanes containing hydrolysable groups, e.g. alkoxy-, thio-, hydroxy- · CPC title
{Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond} in combination with a macromolecular compound other than an unsaturated polymer of groups C09J159/00 - C09J187/00 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.